Tdcp Adolescent and Adult is a vaccine being developed by us for adolescents and adults (above 10 years old) that protects against pertussis, containing slightly increased amount of TT antigen to DTcP vaccine candidate for infants, but reduced amounts of pertussis and DT antigens.

We are developing a Tdcp Adolescent and Adult candidate, which is a potential global best-in-class vaccine with a better formulation and immunogenicity compared to world-class vaccines such as Boostrix and Adacel.